PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2016.5352018501175-182Gemcitabine and Docetaxel Combination for Advanced Soft Tissue Sarcoma: A Nationwide Retrospective StudyYunjung Choi, Mi Sun Yun, Sang Hee Lim, Jeeyun Lee, Jin-Hee Ahn, Yu Jung Kim, Kyong Hwa Park, Young Suk Park, Ho Yeong Lim, Hyonggin An, Dong-Churl Suh, Yeul Hong Kimhttp://www.e-crt.org/upload/pdf/crt-2016-535.pdf, http://www.e-crt.org/journal/view.php?doi=10.4143/crt.2016.535, http://www.e-crt.org/upload/pdf/crt-2016-535.pdf
Frontiers in Oncology10.3389/fonc.2022.922127202212Gemcitabine Plus Anlotinib Is Effective and Safe Compared to Gemcitabine Plus Docetaxel in Advanced Soft Tissue SarcomaZhiyong Liu, Xin Wang, Jiaqiang Wang, Peng Zhang, Chao Li, Bangmin Wang, Guancong Liu, Weitao Yaohttps://www.frontiersin.org/articles/10.3389/fonc.2022.922127/full
Annals of Oncology10.1093/annonc/mdy443.013201829ix128Outcomes of gemcitabine-docetaxel as second-line chemotherapy in patients of advanced soft tissue sarcoma: A retrospective analysisK. Gupta, S. Parthiban, S. Kumar, S. Srinivas, D.H. Vallathol, R. Chanana, G.S. Grewal, N. Rathnasamy, A. Goel, J. Bajpaihttps://api.elsevier.com/content/article/PII:S0923753419433887?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419433887?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/29/suppl_9/mdy443.013/26699106/mdy443.013.pdf
10.21203/rs.2.20871/v22020Soft tissue sarcoma in adolescent and young adult patients: A retrospective study using a nationwide bone and soft tissue tumor registry in Japan.Takashi Fukushima, Koichi Ogura, Toru Akiyama, Katsushi Takeshita, Akira Kawaihttps://www.researchsquare.com/article/rs-11470/v2, https://www.researchsquare.com/article/rs-11470/v2.html
Annals of Oncology10.1093/annonc/mdr2992012233785-790Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimenC.F. Verschraegen, H. Arias-Pulido, S.-J. Lee, S. Movva, L.A. Cerilli, S. Eberhardt, B. Schmit, R. Quinn, C.Y. Muller, I. Rabinowitz, M. Purdy, D. Snyder, T. Bocklagehttps://api.elsevier.com/content/article/PII:S0923753419344539?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419344539?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/23/3/785/13785162/mdr299.pdf
Cancers10.3390/cancers1308198320211381983Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone SarcomaMinggui Pan, Maily K. Trieu, Manpreet Sidhu, Jeanette Yu, Tiffany Seto, Kristen Ganjoohttps://www.mdpi.com/2072-6694/13/8/1983/pdf
Japanese Journal of Clinical Oncology10.1093/jjco/hyab04420215171080-1087Soft tissue sarcoma in adolescent and young adult patients: a retrospective study using a nationwide bone and soft tissue tumor registry in JapanTakashi Fukushima, Koichi Ogura, Toru Akiyama, Katsushi Takeshita, Akira Kawaihttp://academic.oup.com/jjco/article-pdf/51/7/1080/38845219/hyab044.pdf, http://academic.oup.com/jjco/article-pdf/51/7/1080/38845219/hyab044.pdf
Cancer Chemotherapy and Pharmacology10.1007/s00280-011-1742-52011693635-642Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcomaEun Mi Lee, Sun Young Rha, Jeeyun Lee, Kyong Hwa Park, Jin-Hee Ahnhttp://link.springer.com/content/pdf/10.1007/s00280-011-1742-5.pdf, http://link.springer.com/article/10.1007/s00280-011-1742-5/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00280-011-1742-5
10.21203/rs.3.rs-23150/v42020Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcomaZhichao Tian, Fan Zhang, Po Li, Jiaqiang Wang, Jinpo Yang, Peng Zhang, Weitao Yao, Xin Wanghttps://www.researchsquare.com/article/rs-23150/v4, https://www.researchsquare.com/article/rs-23150/v4.html
10.21203/rs.3.rs-23150/v32020Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcomaZhichao Tian, Fan Zhang, Po Li, Jiaqiang Wang, Jinpo Yang, Peng Zhang, Weitao Yao, Xin Wanghttps://www.researchsquare.com/article/rs-23150/v3, https://www.researchsquare.com/article/rs-23150/v3.html